Author: David Johnston
Publisher: Sweet & Maxwell
ISBN: 9780414018389
Category : Limitation of actions
Languages : en
Pages : 488
Book Description
"Published under the auspices of Scottish Universities Institute."
Prescription and limitation
Prescription in Tort Law
Author: European Group on Tort Law
Publisher: Principles of European Tort Law
ISBN: 9781780689630
Category : Comparative law
Languages : en
Pages : 0
Book Description
Prescription is a major legal defence that bars civil actions after the expiry of the prescription period on the claim. This book thoroughly examines the law of 16 selected jurisdictions and extensively analyses in comparative perspective the elements of prescription, their interrelations, and the policy considerations (including economic analysis). While the book focuses on prescription of tort claims the analysis, comparisons and conclusions are most pertinent to most civil actions.
Publisher: Principles of European Tort Law
ISBN: 9781780689630
Category : Comparative law
Languages : en
Pages : 0
Book Description
Prescription is a major legal defence that bars civil actions after the expiry of the prescription period on the claim. This book thoroughly examines the law of 16 selected jurisdictions and extensively analyses in comparative perspective the elements of prescription, their interrelations, and the policy considerations (including economic analysis). While the book focuses on prescription of tort claims the analysis, comparisons and conclusions are most pertinent to most civil actions.
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
A Practical Guide to the Law of Prescription in Scotland
Author: Andrew Foyle
Publisher:
ISBN: 9781912687640
Category :
Languages : en
Pages : 118
Book Description
The Supreme Court rulings in Morrison and Gordon's Trustees, and the forthcoming changes in the Prescription (Scotland) Act 2018 have fundamentally altered an area of law which had been broadly unchanged for over 40 years. This essential guide for practitioners discusses the law of prescription in Scotland.
Publisher:
ISBN: 9781912687640
Category :
Languages : en
Pages : 118
Book Description
The Supreme Court rulings in Morrison and Gordon's Trustees, and the forthcoming changes in the Prescription (Scotland) Act 2018 have fundamentally altered an area of law which had been broadly unchanged for over 40 years. This essential guide for practitioners discusses the law of prescription in Scotland.
Medications for Opioid Use Disorder Save Lives
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Extinctive Prescription on the Limitation of Actions:Reports of the XIVth Congress, International Academy of Comparative Law, Athens (Vouliagmeni), Greece 31 July-7 August 1994
Author: International Academy of Comparative Law
Publisher: Springer
ISBN:
Category : Law
Languages : en
Pages : 428
Book Description
Extinctive Prescription / On the Limitation of Actions contains sixteen national reports and the general report on the subject, written for the XIVth Congress of the International Academy of Comparative Law, held from 31 July-August, 1994, in Athens, Greece. The volume deals with limitations of actions, or `extinctive prescription', as the subject is usually called in civil law jurisdictions. This is both a highly technical and a highly political topic. The book focuses on the political aspects of extinctive prescription; specifically, how long should prescription periods run, as of what event, interrupted by which circumstances, etc. The trend in modern legislation has been to shorten the periods of extinctive prescription. Recent occurrences in biology and medicine, however, have led to proposals to lengthen the limitation periods again. The reports discuss the situation in Europe, Latin America, and North America, and are especially interesting because of their comparative nature.
Publisher: Springer
ISBN:
Category : Law
Languages : en
Pages : 428
Book Description
Extinctive Prescription / On the Limitation of Actions contains sixteen national reports and the general report on the subject, written for the XIVth Congress of the International Academy of Comparative Law, held from 31 July-August, 1994, in Athens, Greece. The volume deals with limitations of actions, or `extinctive prescription', as the subject is usually called in civil law jurisdictions. This is both a highly technical and a highly political topic. The book focuses on the political aspects of extinctive prescription; specifically, how long should prescription periods run, as of what event, interrupted by which circumstances, etc. The trend in modern legislation has been to shorten the periods of extinctive prescription. Recent occurrences in biology and medicine, however, have led to proposals to lengthen the limitation periods again. The reports discuss the situation in Europe, Latin America, and North America, and are especially interesting because of their comparative nature.
Pharmacological Treatment of Mental Disorders in Primary Health Care
Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241547693
Category : Medical
Languages : en
Pages : 80
Book Description
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Publisher: World Health Organization
ISBN: 9241547693
Category : Medical
Languages : en
Pages : 80
Book Description
This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.
Medical and Dental Expenses
Author:
Publisher:
ISBN:
Category : Income tax deductions for medical expenses
Languages : en
Pages : 20
Book Description
Publisher:
ISBN:
Category : Income tax deductions for medical expenses
Languages : en
Pages : 20
Book Description
Delict
Author: Francis McManus
Publisher: Edinburgh University Press
ISBN: 0748697071
Category : Law
Languages : en
Pages : 528
Book Description
"e;Recognising the multi-faceted nature of this Scots law, Francis McManus and Eleanor Russell have produced this all-encompasing guide to delict. With numerous case studies and questions for discussion after each chapter, this is essential reading for all students encountering delict for the first time as well as practitioners who require a ready reference for their practice. The Scots law of delict encompasses a vast array of legal sources and contradictions. Many elements are modern and highly developed while others remain ancient and obscure. The majority of delictual principles are case law driven yet, increasingly, legislation plays a part. Further, although the concept of delict is limited to the Scottish jurisdiction, private international law cannot be ignored. "e;
Publisher: Edinburgh University Press
ISBN: 0748697071
Category : Law
Languages : en
Pages : 528
Book Description
"e;Recognising the multi-faceted nature of this Scots law, Francis McManus and Eleanor Russell have produced this all-encompasing guide to delict. With numerous case studies and questions for discussion after each chapter, this is essential reading for all students encountering delict for the first time as well as practitioners who require a ready reference for their practice. The Scots law of delict encompasses a vast array of legal sources and contradictions. Many elements are modern and highly developed while others remain ancient and obscure. The majority of delictual principles are case law driven yet, increasingly, legislation plays a part. Further, although the concept of delict is limited to the Scottish jurisdiction, private international law cannot be ignored. "e;